Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Research

Independent equity research and analysis from our analyst team

Research

Independent equity research and analysis from our analyst team

Sitowise Q3'26: Turnaround still under construction
Research06.11.2026 klo 14.07
by Atte Jortikka

Sitowise Q3'26: Turnaround still under construction

Based on next year's estimates, the valuation is at the upper end of the neutral range, and the expected return depends on continuing the earnings turnaround in 2028–2029.

Sitowise Group
Orthex Q3'26: What cost pressure?
Research06.11.2026 klo 11.47
by Thomas Westerholm

Orthex Q3'26: What cost pressure?

Orthex's Q3 report dispelled concerns about its ability to defend its margin amid severe cost inflation, as higher raw material prices were reflected in the company's figures in full for the first time.

Orthex
Suominen Q3'26: Profitability improving slowly
Research06.11.2026 klo 09.05
by Rauli Juva

Suominen Q3'26: Profitability improving slowly

The earnings improvement driven by the efficiency program that we forecast will be used to digest multiples.

Suominen

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Enersense Q3'26: Year-end is the proving ground
Research06.11.2026 klo 10.05
by Aapeli Pursimo

Enersense Q3'26: Year-end is the proving ground

In our view, Enersense’s Q3 report was on the soft side overall, given the operating margin, the order book trend, and cash flow.

Enersense International
Tången Industrikapital
Equity brief06.11.2026 klo 08.24

Tången Industrikapital

Tången Industrikapital has kicked off its time on the stock exchange with strong organic growth, a margin in line with its target, and a net cash position that leaves room for further acquisitions.

Tången Industrikapital
Koskisen Q3'26 preview: News flow has been largely negative
Research06.11.2026 klo 20.35
by Antti Viljakainen

Koskisen Q3'26 preview: News flow has been largely negative

We reiterate our Reduce recommendation for Koskisen and lower our target price for the company to EUR 7.50 (was EUR 8.50). We lowered our near-term forecasts for Koskisen significantly following the largely negative news flow in Q3. The cyclical recovery in the construction sector has continuously receded, and we consider the stock to be expensive relative to its weak short-term earnings performance. Consequently, we believe the expected return on Koskisen shares will be modest over our target price horizon, despite our belief that the company has good earnings growth potential once the construction sector eventually turns around.

Koskisen
CapMan Q3'26: Earnings improvement timeline slips
Research06.11.2026 klo 10.22
by Sauli Vilén

CapMan Q3'26: Earnings improvement timeline slips

CapMan's Q3 report was subdued, and the weakened market environment is once again increasing risks regarding the success of major fundraising efforts.

CapMan
Canatu: Cutting-edge tech at a nano price
Research06.11.2026 klo 09.00
by Atte Riikola

Canatu: Cutting-edge tech at a nano price

We feel Canatu's enterprise value (2026e 82 MEUR) has fallen to a very low level relative to the long-term potential of the company's technology.

Canatu
Lemonsoft Q3'26: Market and sales still ripening
Research06.11.2026 klo 11.15
by Atte Riikola

Lemonsoft Q3'26: Market and sales still ripening

The Q3 figures were largely in line with our expectations, and we make only minor downward adjustments to our earnings estimates for the coming years.

Lemonsoft
HKFoods Q3'26: Favorable profitability trend continues
Research05.11.2026 klo 10.21
by Pauli Lohi

HKFoods Q3'26: Favorable profitability trend continues

The valuation is cheap, meaning even modest earnings growth helps drive the share price up.

HKFoods
NYAB Q3'26: Record backlog builds the runway
Research05.11.2026 klo 08.30
by Christoffer Jennel

NYAB Q3'26: Record backlog builds the runway

NYAB's Q3 revenue clearly beat our estimates on a surge in Finland, but the quality of the EBIT beat was weaker. We raise our TP to SEK 9.5 but lower our recommendation to Accumulate.

NYAB
Exel Composites Q3'26: Convincing progress being made on growth story
Research05.11.2026 klo 10.34
by Aapeli Pursimo

Exel Composites Q3'26: Convincing progress being made on growth story

Exel's Q3 figures were clearly better than we expected.

Exel Composites
Metacon Q3'26: Order intake remains dry, but the potential is intact
Research05.11.2026 klo 08.00
by Lucas Mattsson

Metacon Q3'26: Order intake remains dry, but the potential is intact

Metacon's Q3 revenue and earnings were below our expectations, but more in focus for us were order intake and management's comments on the order situation going forward. Order intake continues to be dry, and in our view, the report gave no clear signals that a new order is around the corner.

Metacon
Kempower Q3'26: No turnaround in sight yet in this challenging market
Research05.11.2026 klo 14.28
by Pauli Lohi

Kempower Q3'26: No turnaround in sight yet in this challenging market

Weak demand and oversupply are making the earnings turnaround difficult in the coming years.

Kempower
Sampo Q3'26: Earnings growth outlook remains excellent
Research05.11.2026 klo 11.01
by Sauli Vilén

Sampo Q3'26: Earnings growth outlook remains excellent

Sampo's Q3 was another excellent performance, and the earnings growth outlook remains strong.

Sampo
NORDEN (Investment Case): Underlying earnings drive fifth upward revision
Research04.11.2026 klo 16.00
by Rasmus Køjborg, Jacob Frehr

NORDEN (Investment Case): Underlying earnings drive fifth upward revision

Following the Q3 2026 report, we have updated our investment case. Our updated investment case covers the key investment arguments and risks, as well as valuation perspectives relative to a peer group of dry cargo and product tanker peers.

D/S Norden
Aiforia: Speculative play if you have an appetite for risk
Research04.11.2026 klo 10.08
by Antti Siltanen, Antti Luiro

Aiforia: Speculative play if you have an appetite for risk

Aiforia's share price has clearly fallen since the H1 report, even though the company's outlook remains unchanged.

Aiforia Technologies
Biohit: Market in a gloomy mood
Research04.11.2026 klo 10.43
by Antti Siltanen

Biohit: Market in a gloomy mood

With the share price drop, the defensive business can be acquired at a reasonable price.

Biohit
Remedy Q3'26: Control Resonant sells well, but hopes were higher
Research04.11.2026 klo 09.11
by Atte Riikola

Remedy Q3'26: Control Resonant sells well, but hopes were higher

Our Q3 expectations for Control Resonant were too high, and the game’s initial sales pace looks somewhat more moderate than we previously expected.

Remedy Entertainment
Danske Bank (Investment case): Narrowed guidance on strong Q3 earnings
Research03.11.2026 klo 16.00
by Rasmus Køjborg, William Jørck

Danske Bank (Investment case): Narrowed guidance on strong Q3 earnings

Following Danske Bank’s Q3 2026 interim report, we have updated our investment case on the company. Our updated investment case covers the key investment reasons, risks, and valuation perspective relative to peers across Nordic large-cap banking.

Danske Bank